Cargando…
Inhibition of HMGB1 Might Enhance the Protective Effect of Taxifolin in Cardiomyocytes via PI3K/AKT Signaling Pathway
Cardiovascular diseases (CVD) affect millions of people and spend a lot of medical costs around the world each year. Taxifolin is a natural anti-oxidative reagent obtained from multiple plants and exhibits a wide range of pharmacological effects. High mobility group box protein 1 (HMGB1) is expresse...
Autores principales: | Feng, Erjun, Wang, Jian, Wang, Xinwei, Wang, Zhenguo, Chen, Xiaochu, Zhu, Xu, Hou, Wenli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shaheed Beheshti University of Medical Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457741/ https://www.ncbi.nlm.nih.gov/pubmed/34567165 http://dx.doi.org/10.22037/ijpr.2020.113584.14384 |
Ejemplares similares
-
Activation of PI3Kγ/Akt pathway increases cardiomyocyte HMGB1 expression in diabetic environment
por: Song, Jia, et al.
Publicado: (2016) -
Taxifolin Targets PI3K and mTOR and Inhibits Glioblastoma Multiforme
por: Yao, Weiqi, et al.
Publicado: (2021) -
Low concentration of rutin treatment might alleviate the cardiotoxicity effect of pirarubicin on cardiomyocytes via activation of PI3K/AKT/mTOR signaling pathway
por: Fei, Junjie, et al.
Publicado: (2019) -
Taxifolin and Sorghum Ethanol Extract Protect against Hepatic Insulin Resistance via the miR-195/IRS1/PI3K/AKT and AMPK Signalling Pathways
por: Lee, Hana, et al.
Publicado: (2021) -
HMGB1 Protects the Heart Against Ischemia–Reperfusion Injury via PI3K/AkT Pathway-Mediated Upregulation of VEGF Expression
por: Zhou, Yan-Hong, et al.
Publicado: (2020)